As of 2025-07-22, the Intrinsic Value of Idera Pharmaceuticals Inc (IDRA) is -11.37 USD. This IDRA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.43 USD, the upside of Idera Pharmaceuticals Inc is -2,775.91%.
Based on its market price of 0.43 USD and our intrinsic valuation, Idera Pharmaceuticals Inc (IDRA) is overvalued by 2,775.91%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -11.37 - -11.37 | -11.37 | -2,775.91% |
| P/E | (4.37) - (5.91) | (4.94) | -1261.3% |
| DDM - Stable | (3.26) - (14.49) | (8.87) | -2187.8% |
| DDM - Multi | (2.73) - (10.16) | (4.39) | -1131.8% |
| Market Cap (mil) | 21.82 |
| Beta | 1.25 |
| Outstanding shares (mil) | 51.35 |
| Enterprise Value (mil) | 19.71 |
| Market risk premium | 5.00% |
| Cost of Equity | 10.30% |
| Cost of Debt | 5.00% |
| WACC | 6.99% |